T. Rowe Price Associates’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.9M Buy
287,727
+1,992
+0.7% +$165K ﹤0.01% 921
2025
Q1
$24M Buy
285,735
+956
+0.3% +$80.2K ﹤0.01% 910
2024
Q4
$26.2M Buy
284,779
+1,680
+0.6% +$155K ﹤0.01% 921
2024
Q3
$26.3M Buy
283,099
+3,817
+1% +$355K ﹤0.01% 935
2024
Q2
$23M Buy
279,282
+273,639
+4,849% +$22.5M ﹤0.01% 924
2024
Q1
$375K Buy
5,643
+695
+14% +$46.2K ﹤0.01% 2327
2023
Q4
$281K Buy
4,948
+517
+12% +$29.4K ﹤0.01% 2403
2023
Q3
$242K Buy
4,431
+469
+12% +$25.6K ﹤0.01% 2425
2023
Q2
$267K Buy
+3,962
New +$267K ﹤0.01% 2413
2021
Q4
Sell
-10,014
Closed -$532K 3016
2021
Q3
$532K Buy
10,014
+54
+0.5% +$2.87K ﹤0.01% 2353
2021
Q2
$608K Sell
9,960
-2,740
-22% -$167K ﹤0.01% 2290
2021
Q1
$620K Sell
12,700
-18
-0.1% -$879 ﹤0.01% 2260
2020
Q4
$515K Sell
12,718
-99
-0.8% -$4.01K ﹤0.01% 2223
2020
Q3
$417K Hold
12,817
﹤0.01% 2163
2020
Q2
$338K Sell
12,817
-3,148
-20% -$83K ﹤0.01% 2208
2020
Q1
$398K Buy
15,965
+228
+1% +$5.68K ﹤0.01% 2084
2019
Q4
$566K Buy
15,737
+657
+4% +$23.6K ﹤0.01% 2107
2019
Q3
$515K Buy
15,080
+117
+0.8% +$4K ﹤0.01% 2078
2019
Q2
$419K Hold
14,963
﹤0.01% 2172
2019
Q1
$464K Buy
14,963
+2,950
+25% +$91.5K ﹤0.01% 2137
2018
Q4
$284K Sell
12,013
-3,671
-23% -$86.8K ﹤0.01% 2297
2018
Q3
$608K Buy
15,684
+96
+0.6% +$3.72K ﹤0.01% 2072
2018
Q2
$522K Buy
15,588
+3,417
+28% +$114K ﹤0.01% 2114
2018
Q1
$441K Buy
12,171
+29
+0.2% +$1.05K ﹤0.01% 2125
2017
Q4
$387K Buy
12,142
+3,800
+46% +$121K ﹤0.01% 2167
2017
Q3
$312K Buy
8,342
+5
+0.1% +$187 ﹤0.01% 2257
2017
Q2
$260K Hold
8,337
﹤0.01% 2290
2017
Q1
$205K Hold
8,337
﹤0.01% 2391
2016
Q4
$211K Buy
+8,337
New +$211K ﹤0.01% 2368